Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Incontinence, prolapse & sacral neuromodulation · Ohio | Incontinence, prolapse & sacral neuromodulation · Illinois | |
|---|---|---|
| Surgeons, 2024 | 37 | 39 |
| Medicare fee-for-service cases | 2,896 | 2,574 |
| Growth since 2019 (Medicare FFS) | −3.5%/yr | −0.2%/yr |
| Forecast cases (Medicare FFS) | 2,970 in 2030 | 3,390 in 2030 |
| Forecast growth | +0.4%/yr to 2030 | +4.7%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 2.6 | 1.9 |
| Medicare Advantage share | 60% | 47% |
| Out of hospital | 7% (+2 pts since 2019) | 8% (+4 pts since 2019) |
| Cases per surgeon | 78 | 66 |
| Top 10 surgeons' share | 54% | 47% |
| Surgeons growing | 7 | 9 |
| New since the base year | 3 | 9 |
| Likely to stop billing it | 8 by 2026 | 6 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | $17K | $7,995 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.